Huntington's Disease Chorea Improved With Valbenazine

(MedPage Today) -- Valbenazine (Ingrezza) calmed the involuntary, jerky movements associated with Huntington's disease, the phase III KINECT-HD trial showed. In the 12-week double-blind trial, the Unified Huntington's Disease Rating Scale Total...
Source: MedPage Today Neurology - Category: Neurology Source Type: news